Net profit of JFL Life Sciences rose 172.97% to Rs 2.02 crore in the quarter ended December 2025 as against Rs 0.74 crore during the previous quarter ended December 2024. Sales rose 26.31% to Rs 26.84 crore in the quarter ended December 2025 as against Rs 21.25 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales26.8421.25 26 OPM %12.486.35 - PBDT2.981.15 159 PBT2.710.99 174 NP2.020.74 173 Powered by Capital Market - Live News

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live News

Net profit of JFL Life Sciences rose 35.86% to Rs 1.97 crore in the quarter ended September 2025 as against Rs 1.45 crore during the previous quarter ended September 2024. Sales declined 24.30% to Rs 29.91 crore in the quarter ended September 2025 as against Rs 39.51 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales29.9139.51 -24 OPM %9.736.07 - PBDT2.482.13 16 PBT2.211.89 17 NP1.971.45 36 Powered by Capital Market - Live News

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

JFL Life Sciences announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 October 2025.Powered by Capital Market - Live News